Monitor for the company's IPO pricing and the automatic conversion of preferred stock into common shares, which will determine the public float and OrbiMed's resulting common stock position.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.89entry
- T+1 · 6d ago −12.42%α −11.95% · $13.04
- T+5 · due 11h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC filed an initial statement of beneficial ownership (Form 3) for Aspen Neuroscience, Inc., disclosing holdings of convertible preferred stock that convert into common stock on a 1-for-9.8821 basis upon the IPO. The filing is a routine insider ownership disclosure with no material financial data or trading activity.
Key Facts
- OrbiMed Advisors LLC and OrbiMed Capital GP VII LLC filed Form 3 as reporting persons for Aspen Neuroscience, Inc.
- Holdings include Series Seed-2, A-1, A-2, B, and C Convertible Preferred Stock, convertible to common on a 1-for-9.8821 basis upon IPO.
- Converted common share equivalents: 196,541 (Seed-2), 642,745 (A-1), 616,984 (A-2), 625,743 (B), 507,119 (C).
- Securities are held by OrbiMed Private Investments VII, LP; OrbiMed GP is the general partner; OrbiMed Advisors is the managing member.
- Peter Thompson, a member of OrbiMed Advisors, serves on the issuer's board of directors.
Financial Impact
No financial impact; disclosure of pre-IPO convertible preferred holdings with no transaction or change in ownership.
Risk Factors
- No trading activity or material financial data disclosed; filing is purely informational.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000947871-26-000964 |
| Document: 0000947871-26-000964-index.html | 0000947871-26-000964 |
| Document: 0000947871-26-000964.txt | 0000947871-26-000964 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers